"Leishmaniasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Descriptor ID |
D007896
|
| MeSH Number(s) |
C03.752.300.500 C03.858.560 C17.800.838.775.560
|
| Concept/Terms |
Leishmaniasis- Leishmaniasis
- Leishmaniases
- Leishmania Infection
- Infection, Leishmania
- Infections, Leishmania
- Leishmania Infections
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis".
This graph shows the total number of publications written about "Leishmaniasis" by people in this website by year, and whether "Leishmaniasis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis" by people in Profiles.
-
Myotubularin-related protein-6 silencing protects mice from Leishmania donovani infection. Int Immunopharmacol. 2024 Mar 10; 129:111589.
-
Neglected tropical disease vaccines: hookworm, leishmaniasis, and schistosomiasis. Vaccine. 2023 Nov 03; 41 Suppl 2:S176-S179.
-
Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis. Vaccine. 2023 08 23; 41(37):5400-5411.
-
A short-term method to evaluate anti-leishmania drugs by inhibition of stage differentiation in Leishmania mexicana using flow cytometry. Exp Parasitol. 2023 Jun; 249:108519.
-
How I Approach Leishmaniasis: Diagnosis and Treatment in the United States. J Pediatric Infect Dis Soc. 2022 Dec 05; 11(11):525-532.
-
Bidirectional cytokine-microRNA control: A novel immunoregulatory framework in leishmaniasis. PLoS Pathog. 2022 08; 18(8):e1010696.
-
The expression of PD-1 and its ligands increases in Leishmania infection and its blockade reduces the parasite burden. Cytokine. 2022 05; 153:155839.
-
Cytokines and metabolic regulation: A framework of bidirectional influences affecting Leishmania infection. Cytokine. 2021 11; 147:155267.
-
Neglected tropical diseases in children: An assessment of gaps in research prioritization. PLoS Negl Trop Dis. 2019 01; 13(1):e0007111.
-
The rise of leishmaniasis in the twenty-first century. Trans R Soc Trop Med Hyg. 2018 09 01; 112(9):421-422.